Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study
Rea, Delphine, Nicolini, Franck E., Tulliez, Michel, Guilhot, François, Guilhot, Joelle, Guerci-Bresler, Agnès, Gardembas, Martine, Coiteux, Valérie, Guillerm, Gaelle, Legros, Laurence, Etienne, Gabriel, Pignon, Jean-Michel, Villemagne, Bruno, Escoffre-Barbe, Martine, Ianotto, Jean-Christophe, Charbonnier, Aude, Johnson-Ansah, Hyacinthe, Noel, Marie-Pierre, Rousselot, Philippe, Mahon, François-Xavier
Published in Blood (16.02.2017)
Published in Blood (16.02.2017)
Get full text
Journal Article
Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable Disease
ROUSSELOT, Philippe, CHARBONNIER, Aude, ESCOFFRE-BARBE, Martine, GUERCI-BRESLER, Agnès, TULLIEZ, Michel, PROST, Stéphane, SPENTCHIAN, Marc, CAYUELA, Jean Michel, REIFFERS, Josy, CHOMEL, Jean Claude, TURHAN, Ali, GUILHOT, Joëlle, CONY-MAKHOUL, Pascale, GUILHOT, François, MAHON, François-Xavier, AGAPE, Philippe, NICOLINI, Franck E, VARET, Bruno, GARDEMBAS, Martine, ETIENNE, Gabriel, REA, Delphine, ROY, Lydia
Published in Journal of clinical oncology (10.02.2014)
Published in Journal of clinical oncology (10.02.2014)
Get full text
Journal Article
Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia
Delgado, Livia, MD, Giraudier, Stephane, PhD, Ortonne, Nicolas, PhD, Zehou, Ouidad, MD, Cordonnier, Catherine, MD, Hulin, Anne, PhD, Chosidow, Olivier, PhD, Tulliez, Michel, MD, Valeyrie-Allanore, Laurence, MD
Published in Journal of the American Academy of Dermatology (01.11.2013)
Published in Journal of the American Academy of Dermatology (01.11.2013)
Get full text
Journal Article
Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: A prospective study of 54 patients
Valeyrie, Laurence, Bastuji-Garin, Sylvie, Revuz, Jean, Bachot, Nicolas, Wechsler, Janine, Berthaud, Patrice, Tulliez, Michel, Giraudier, Stéphane
Published in Journal of the American Academy of Dermatology (01.02.2003)
Published in Journal of the American Academy of Dermatology (01.02.2003)
Get full text
Journal Article
Cartridge-based automated BCR-ABL1 mRNA quantification: solving the issues of standardization, at what cost?
CAYUELA, Jean-Michel, MACINTYRE, Elizabeth, SEROR, Valerie, DARLINGTON, Meryl, ABDELALI, Raouf Ben, FUND, Xavier, VILLARESE, Patrick, TULLIEZ, Michel, RAFFOUX, Emmanuel, SIGAUX, François, REA, Delphine
Published in Haematologica (Roma) (01.05.2011)
Published in Haematologica (Roma) (01.05.2011)
Get full text
Journal Article
Congenital Dyserythropoietic Anemia Type I Is Caused by Mutations in Codanin-1
Dgany, Orly, Avidan, Nili, Delaunay, Jean, Krasnov, Tatyana, Shalmon, Lea, Shalev, Hanna, Eidelitz-Markus, Tal, Kapelushnik, Joseph, Cattan, Daniel, Pariente, Alexandre, Tulliez, Michel, Crétien, Aurore, Schischmanoff, Pierre-Olivier, Iolascon, Achille, Fibach, Eithan, Koren, Ariel, Rössler, Jochen, Le Merrer, Martine, Yaniv, Isaac, Zaizov, Rina, Ben-Asher, Edna, Olender, Tsvyia, Lancet, Doron, Beckmann, Jacques S., Tamary, Hannah
Published in American journal of human genetics (01.12.2002)
Published in American journal of human genetics (01.12.2002)
Get full text
Journal Article
Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation
Nicolini, Franck E, Hayette, Sandrine, Corm, Selim, Bachy, Emmanuel, Bories, Dominique, Tulliez, Michel, Guilhot, Francois, Legros, Laurence, Maloisel, Frederic, Kiladjian, Jean-Jacques, Mahon, Francois-Xavier, Le, Quoc-Hung, Michallet, Mauricette, Roche-Lestienne, Catherine, Preudhomme, Claude
Published in Haematologica (Roma) (01.09.2007)
Published in Haematologica (Roma) (01.09.2007)
Get full text
Journal Article
Pegylated IFN-α2a combined to imatinib mesylate 600mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600mg daily alone
Nicolini, Franck E, Hayette, Sandrine, Legros, Laurence, Rousselot, Philippe, Maloisel, Frédéric, Tulliez, Michel, Guerci, Agnès, Charbonnier, Aude, Prébet, Thomas, Rigal-Huguet, Françoise, Chabane, Kaddour, Magaud, Jean-Pierre, Paillet, Carole, Pivot, Christine, Michallet, Mauricette
Published in Leukemia research (01.01.2011)
Published in Leukemia research (01.01.2011)
Get full text
Journal Article
Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia
Etienne, Gabriel, Guilhot, Joëlle, Rea, Delphine, Rigal-Huguet, Françoise, Nicolini, Franck, Charbonnier, Aude, Guerci-Bresler, Agnès, Legros, Laurence, Varet, Bruno, Gardembas, Martine, Dubruille, Viviane, Tulliez, Michel, Noel, Marie-Pierre, Ianotto, Jean-Christophe, Villemagne, Bruno, Carré, Martin, Guilhot, François, Rousselot, Philippe, Mahon, François-Xavier
Published in Journal of clinical oncology (20.01.2017)
Published in Journal of clinical oncology (20.01.2017)
Get full text
Journal Article
Prognostication of Molecular Relapses after Dasatinib or Nilotinib Discontinuation in Chronic Myeloid Leukemia (CML): A FI-LMC STOP 2G-TKI Study Update
Rea, Delphine, Nicolini, Franck E, Tulliez, Michel, Rousselot, Philippe, Gardembas, Martine, Etienne, Gabriel, Guilhot, Francois, Guilhot, Joelle, Guerci, Agnès, Escoffre-Barbe, Martine, Legros, Laurence, Villemagne, Bruno, Guillerm, Gaëlle, Noel, Marie-Pierre, Coiteux, Valerie, Pignon, Jean-Michel, Mahon, Francois-Xavier
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Quality Of Life In CML Patients: Better Outcomes Associated With TKI Interruption
Giraudier, Stephane, Audureau, Etienne, Oukerfellah, Kahina, Tulliez, Michel
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Emergence of MPLW515 mutation in a patient with CALR deletion: Evidence of secondary acquisition of MPL mutation in the CALR clone
Partouche, Nicolas, Conejero, Carole, Barathon, Quentin, Moroch, Julien, Tulliez, Michel, Cordonnier, Catherine, Giraudier, Stephane
Published in Hematological oncology (01.02.2018)
Published in Hematological oncology (01.02.2018)
Get full text
Journal Article
Second attempt to discontinue imatinib in CP-CML patients with a second sustained complete molecular response
Legros, Laurence, Rousselot, Philippe, Giraudier, Stéphane, Tulliez, Michel, Huguet, Françoise, Nicolini, Franck-Emmanuel, Mahon, Francois-Xavier
Published in Blood (30.08.2012)
Published in Blood (30.08.2012)
Get full text
Journal Article
Impact of ELN recommendations in the management of first‐line treated chronic myeloid leukaemia patients: a French cross‐sectional study
Etienne, Gabriel, Huguet, Francoise, Guerci‐Bresler, Agnès, Nicolini, Franck E., Maloisel, Frédéric, Coiteux, Valérie, Dauriac, Charles, Carpentier, Nathalie, Bourdeix, Isabelle, Tulliez, Michel, Cony‐Makhoul, Pascale
Published in British journal of haematology (01.07.2016)
Published in British journal of haematology (01.07.2016)
Get full text
Journal Article
Reversible lymph node follicular hyperplasia associated with dasatinib treatment of chronic myeloid leukemia in chronic phase
Roux, Clémence, Nicolini, Franck-Emmanuel, Rea, Delphine, Niault, Mathilde, Mollica, Luigina, Berger, Françoise, Chassagne-Clément, Catherine, Tigaud, Isabelle, Tulliez, Michel, Giraudier, Stéphane, Turhan, Ali, Rousselot, Philippe, Legros, Laurence
Published in Blood (24.10.2013)
Published in Blood (24.10.2013)
Get full text
Journal Article
Reply to J. Richter et al
Rousselot, Philippe, Charbonnier, Aude, Cony-Makhoul, Pascale, Agape, Philippe, Nicolini, Franck E, Varet, Bruno, Gardembas, Martine, Etienne, Gabriel, Réa, Delphine, Roy, Lydia, Escoffre-Barbe, Martine, Guerci-Bresler, Agnès, Tulliez, Michel, Prost, Stéphane, Spentchian, Marc, Cayuela, Jean Michel, Reiffers, Josy, Chomel, Jean Claude, Turhan, Ali, Guilhot, Joëlle, Guilhot, François, Mahon, François-Xavier
Published in Journal of clinical oncology (01.09.2014)
Published in Journal of clinical oncology (01.09.2014)
Get full text
Journal Article
Dasatinib or Nilotinib Discontinuation in Chronic Phase (CP)-Chronic Myeloid Leukemia (CML) Patients (pts) with Durably Undetectable BCR-ABL Transcripts: Interim Analysis of the STOP 2G-TKI Study with a Minimum Follow-up of 12 Months – on Behalf of the French CML Group Filmc
Rea, Delphine, Nicolini, Franck E., Tulliez, Michel, Rousselot, Philippe, Guilhot, Francois, Gardembas, Martine, Guerci, Agnès, Coiteux, Valérie, Legros, Laurence, Guillerm, Gaelle, Pignon, Jean Michel, Giraudier, Stephane, Etienne, Gabriel, Villemagne, Bruno, Escoffre, Martine, Charbonnier, Aude, Mahon, Francois-Xavier
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Toxicological evaluation of RGTA OTR4120, a heparan sulfate mimetic
Charef, Said, Tulliez, Michel, Esmilaire, Liliane, Courty, José, Papy-Garcia, Dulce
Published in Food and chemical toxicology (01.07.2010)
Published in Food and chemical toxicology (01.07.2010)
Get full text
Journal Article